Autologous adipose tissue implant with concentrated stem cells
View Patent ↗Cells present in processed lipoaspirate tissue are used to treat patients. Methods of treating patients include processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient. The methods may be practiced in a closed system so that the stem cells are not exposed to an external environment prior to being administered to a patient. Compositions that are administered to a patient include a mixture of adipose tissue and stem cells so that the composition has a higher concentration of stem cells than when the adipose tissue was removed from the patient.
1. An autologous adipose tissue implant comprising:
a first portion of intact (non-disaggregated) adipose tissue removed from a patient mixed with a concentrated population of adipose-derived cells that comprises stem cells,
wherein the population of adipose-derived cells comprising stem cells is concentrated from a second portion of adipose tissue removed from the same patient, and
wherein the stem cell concentration in the concentrated population of adipose-derived cells that comprises stem cells is more than 1.7×10 5 cells/ml.
2. The autologous adipose tissue implant of claim 1 , wherein the stem cell concentration in the concentrated population of adipose-derived cells that comprises stem cells is more than 2.1×10 5 cells/ml.
3. The autologous adipose tissue implant of claim 1 , wherein the stem cell concentration in the concentrated population of adipose-derived cells that comprises stem cells is more than 2.5×10 5 cells/ml.
4. The adipose tissue implant of claim 1 , further comprising an additive.
5. The adipose tissue implant of claim 4 , wherein said additive is selected from the group consisting of growth factors, cytokines, a preformed matrix, cells, tissue, tissue fragments, disaggregating agents, antimicrobial agents, scaffolds, immunosuppressive agents, and antibiotics, or any combination thereof.
6. The adipose tissue implant of claim 1 , wherein said concentrated population of adipose-derived cells that comprises stem cells is not cultured.
7. The adipose tissue implant of claim 1 , wherein said concentrated population of adipose-derived cells that comprises stem cells is cultured.
8. The adipose tissue implant of claim 1 , wherein said concentrated population of adipose-derived cells that comprises stem cells is isolated in a closed, sterile fluid/tissue pathway.
9. The adipose tissue implant of claim 1 , wherein the first, second, or both portions are cryopreserved after removal from the patient.
10. An autologous adipose tissue implant, comprising:
a first portion of intact (non-disaggregated) adipose tissue comprising connective tissue removed from a patient, mixed with a concentrated population of adipose-derived cells that comprises stem cells, wherein the population of adipose-derived cells comprising stem cells is concentrated from a second portion of adipose tissue that is removed from the same patient and enzymatically treated, wherein the stem cell concentration in the concentrated population of adipose-derived cells that comprises stem cells is more than 1.7×10 5 cells/ml.
11. The autologous adipose tissue implant of claim 10 , wherein the stem cell concentration in the concentrated population of adipose-derived cells that comprises stem cells is more than 2.1×10 5 cells/ml.
12. The autologous adipose tissue implant of claim 10 , wherein the stem cell concentration in the concentrated population of adipose-derived cells that comprises stem cells is more than 2.5×10 5 cells/ml.
13. The adipose tissue implant of claim 10 , further comprising an additive.
14. The adipose tissue implant of claim 13 , wherein said additive is selected from the group consisting of growth factors, cytokines, a preformed matrix, cells, tissue, tissue fragments, disaggregating agents, antimicrobial agents, scaffolds, immunosuppressive agents, and antibiotics, or any combination thereof.
15. The adipose tissue implant of claim 10 , wherein said concentrated population of adipose-derived cells that comprises stem cells is not cultured.
16. The adipose tissue implant of claim 10 , wherein said concentrated population of adipose-derived cells that comprises stem cells is cultured.
17. The adipose tissue implant of claim 10 , wherein said concentrated population of adipose-derived cells that comprises stem cells is isolated in a closed, sterile fluid/tissue pathway.
18. The adipose tissue implant of claim 10 , wherein the first, second, or both portions are cryopreserved after removal from the patient.